Animal models of arthritis generated by gene transfer

[1]  B. Hall,et al.  Divide, accumulate, differentiate: cell condensation in skeletal development revisited. , 2004, The International journal of developmental biology.

[2]  S. Wahl,et al.  Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. , 1998, The Journal of clinical investigation.

[3]  E. Lechman,et al.  Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A I Caplan,et al.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. , 1998, Experimental cell research.

[5]  Simon C Watkins,et al.  Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. , 1997, Journal of immunology.

[6]  K. M. Mulder,et al.  Transforming growth factor-beta signaling in epithelial cells. , 1997, Pharmacology & therapeutics.

[7]  Y. Chernajovsky,et al.  Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model , 1997, Gene Therapy.

[8]  D. Barritault,et al.  Growth factors in skeletal muscle regeneration. , 1996, Cytokine & growth factor reviews.

[9]  M. Rn,et al.  The Role of Cytokines in Rheumatoid Arthritis , 1996, Journal of the Royal College of Physicians of London.

[10]  Simon C Watkins,et al.  Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. , 1996, Human gene therapy.

[11]  G. Bandara,et al.  Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. , 1996, Arthritis and rheumatism.

[12]  P. Robbins,et al.  Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. , 1996, Journal of immunology.

[13]  D. Reid,et al.  Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate:creatinine ratio. , 1996, Arthritis and rheumatism.

[14]  K. Eguchi,et al.  Increased nitric oxide levels in patients with rheumatoid arthritis. , 1996, The Journal of rheumatology.

[15]  S. Collier,et al.  Effects of transforming growth factor beta on proteoglycan synthesis by cell and explant cultures derived from the knee joint meniscus. , 1995, Osteoarthritis and cartilage.

[16]  J. Lancaster,et al.  Nitric oxide and its role in orthopaedic disease. , 1995, Clinical orthopaedics and related research.

[17]  C. Dinarello,et al.  The interleuldn-1 family: 10 years of discovery’ , 2004 .

[18]  C. Evans,et al.  N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. , 1994, Arthritis and rheumatism.

[19]  E. Furth,et al.  Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Zitvogel,et al.  Retroviral Vectors for Use in Human Gene Therapy for Cancer, Gaucher Disease, and Arthritis a , 1994, Annals of the New York Academy of Sciences.

[21]  S Moncada,et al.  Nitric oxide synthases in mammals. , 1994, The Biochemical journal.

[22]  A. Mauviel.  Cytokine regulation of metalloproteinase gene expression , 1993, Journal of cellular biochemistry.

[23]  G. Bandara,et al.  Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Nussler,et al.  Inflammation, immunoregulation, and inducible nitric oxide synthase , 1993, Journal of leukocyte biology.

[25]  B. Davidson,et al.  Adenoviral-mediated gene transfer to rabbit synovium in vivo. , 1993, The Journal of clinical investigation.

[26]  S. Wahl,et al.  Suppression of arthritis by an inhibitor of nitric oxide synthase , 1993, The Journal of experimental medicine.

[27]  S. Moncada,et al.  Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. , 1992, Annals of the rheumatic diseases.

[28]  W. Cooper,et al.  Acceleration of onset of collagen‐induced arthritis by intra‐articular injection of tumour necrosis factor or transforming growth factor‐beta , 1992, Clinical and experimental immunology.

[29]  J. Sanes,et al.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos , 1991, Molecular and cellular biology.

[30]  M. Feldmann,et al.  Transforming growth factor‐β1 in rheumatoid synovial membrane and cartilage pannus junction , 1991, Clinical and experimental immunology.

[31]  S. Wahl,et al.  Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta , 1990, The Journal of experimental medicine.

[32]  J. Gimble,et al.  Differential effects of TGF-beta 1 on lymphohemopoiesis in long-term bone marrow cultures , 1989 .

[33]  J. Larrick,et al.  Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta , 1989, The Journal of cell biology.

[34]  B. Henderson,et al.  Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. , 1989, Clinical and experimental immunology.

[35]  T. Pincus,et al.  Active and latent forms of transforming growth factor beta activity in synovial effusions , 1989, The Journal of experimental medicine.

[36]  J. Dingle,et al.  In vivo studies of articular tissue damage mediated by catabolin/interleukin 1. , 1987, Annals of the rheumatic diseases.

[37]  B Henderson,et al.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis. , 1996, Annual review of immunology.

[39]  G. Duff.  Cytokines and acute phase proteins in rheumatoid arthritis. , 1994, Scandinavian journal of rheumatology. Supplement.

[40]  A. Karbowski,et al.  Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint. , 1989, International journal of tissue reactions.